Angiodynamics Inc. (ANGO) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Angiodynamics Inc. (ANGO:NASDAQ), powered by AI.

Current Price
$12.15
P/E Ratio
-14.6
Market Cap
496M
Sector
Healthcare
What is the Angiodynamics Inc. stock price forecast?

Angiodynamics Inc. is currently trading at $12.15. View real-time AI analysis on Alpha Lenz.

What is Angiodynamics Inc. insider trading activity?

View the latest insider trading data for Angiodynamics Inc. on Alpha Lenz.

What is Angiodynamics Inc.'s P/E ratio?

Angiodynamics Inc.'s P/E ratio is -14.6.

Angiodynamics Inc.

NASDAQ · ANGO
$12.15+0.17(+1.42%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Angiodynamics Inc.'s future dividend policy...
Alpha Chat Insight

Angiodynamics Inc. trades at a P/E of -14.6 (undervalued) with modest ROE of -17.5%.

Ask for details

Company Overview

Angiodynamics Inc. is a prominent player in the medical device industry, specializing in the development, manufacture, and sale of minimally invasive medical, surgical, and diagnostic devices used by healthcare professionals around the globe. Their product portfolio spans several key areas, including oncology, vascular interventions, and peripheral disease solutions, focusing on innovative technologies that enhance patient care and improve medical outcomes. Angiodynamics places a strong emphasis on research and development, driving advancements in products such as radiofrequency ablation devices, angiographic catheters, and other vascular access products. With a widespread impact across various healthcare sectors, Angiodynamics is committed to addressing critical medical challenges and enhancing operational efficiency in surgical procedures. The company's strategic initiatives and collaborations aim to expand their market presence and influence, continuously adapting to the evolving needs of medical facilities and professionals. As a crucial contributor to the healthcare technology landscape, Angiodynamics plays a vital role in facilitating advancements in patient-focused treatment modalities, solidifying its importance within the healthcare field.

CEOMr. James C. Clemmer
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees675

Company Statistics

FY 2025

Profile

$496.36MMarket Cap
$292.50MRevenue
0.00Shares Out
675Employees

Margins

53.92%Gross
6.03%EBITDA
-8.23%Operating
-11.63%Pre-Tax
-11.62%Net

Valuation

-14.60P/E
2.71P/B
1.70EV/Sales
24.98EV/EBITDA
-34.02P/FCF

Growth (CAGR)

-2.57%Rev 3Yr
2.06%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-11.37%ROA
-17.50%ROE
-8.05%ROIC

Financial Health

$55.89MCash & Cash Equivalents
$41.28MNet Debt
53.11%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Angiodynamics Inc. (ticker: ANGO) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 675 employees. Market cap is $496M.

The current price is $12.15 with a P/E ratio of -14.6x and P/B of 2.71x.

ROE is -17.50% and operating margin is -8.23%. Annual revenue is $292M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Angiodynamics Inc. (ANGO) Stock Forecast 2026 $12.15 — Price, Financials & Analyst Targets | Alpha Lenz